Pregnant or lactating women. 
Evolutive skin disease on the testing zone (lower back). 
Patients with a clinically significant disease (chronic, recurrent or active). 
Systemic corticotherapy or immunosuppressive treatment during the previous month, or local corticoid treatment the week before the patch testing. 
Local or systemic drug use which interacts with the outcome measures. 
Exposure to sun or UV radiations, 15 days before the patch testing. 
Patients deprived of their civic rights, in custody, or subject to a tutorial, judiciary or administrative decision. 
Patients subject to a protection measure. 
Patients in a critical medical situation. 
Patients with a personal situation judged by the investigator as unlikely to be compatible with optimal participation in the study, or which could constitute a risk for the patient. 
Linguistic barrier or psychological profile preventing the patient from signing the consent form. 
Patient still in an exclusion period following the participation in another clinical trial. 
Patients having earned more than 4500€ in indemnities for participation in clinical trials during the previous 12 months, including this study.       
    

NCT00445029_exc_T1
Condition
Pregnant
NCT00445029_exc_T2
Condition
lactating
NCT00445029_exc_T3
Person
women
NCT00445029_exc_T4
Condition
Evolutive skin disease
NCT00445029_exc_T5
Qualifier
testing zone
NCT00445029_exc_T6
Qualifier
lower back
NCT00445029_exc_T7
Procedure
Systemic corticotherapy
NCT00445029_exc_T8
Procedure
immunosuppressive treatment
NCT00445029_exc_T9
Temporal
during the previous month
NCT00445029_exc_T10
Scope
Systemic corticotherapy or immunosuppressive treatment
NCT00445029_exc_T11
Procedure
local corticoid treatment
NCT00445029_exc_T12
Temporal
the week before
NCT00445029_exc_T13
Condition
Exposure to sun
NCT00445029_exc_T14
Condition
Exposure to UV radiations
NCT00445029_exc_T15
Temporal
15 days before the patch testing
NCT00445029_exc_T16
Scope
Exposure to sun or UV radiations
NCT00445029_exc_T17
Condition
deprived of their civic rights
NCT00445029_exc_T18
Condition
in custody
NCT00445029_exc_T19
Condition
subject to a tutorial
NCT00445029_exc_T20
Condition
subject to a judiciary decision
NCT00445029_exc_T21
Condition
subject to administrative decision
NCT00445029_exc_T22
Condition
critical medical situation
NCT00445029_exc_T23
Condition
subject to a protection measure
NCT00445029_exc_T24
Qualifier
clinically significant
NCT00445029_exc_T25
Condition
disease
NCT00445029_exc_T26
Qualifier
chronic
NCT00445029_exc_T27
Qualifier
recurrent
NCT00445029_exc_T28
Qualifier
active
NCT00445029_exc_T29
Scope
chronic, recurrent or active
NCT00445029_exc_T30
Qualifier
Local
NCT00445029_exc_T31
Qualifier
systemic
NCT00445029_exc_T32
Drug
drug
NCT00445029_exc_T33
Qualifier
interacts with the outcome measures
NCT00445029_exc_T34
Scope
Local or systemic
NCT00445029_exc_T35
Reference_point
the patch testing
NCT00445029_exc_T36
Observation
personal situation
NCT00445029_exc_T39
Scope
judged by the investigator as unlikely to be compatible with optimal participation in the study, or which could constitute a risk for the patient
NCT00445029_exc_T40
Observation
Linguistic barrier
NCT00445029_exc_T41
Condition
psychological profile
NCT00445029_exc_T42
Negation
preventing
NCT00445029_exc_T44
Scope
Linguistic barrier or psychological profile
NCT00445029_exc_T46
Temporal
still in an exclusion period following
NCT00445029_exc_T48
Temporal
during the previous 12 months
NCT00445029_exc_T49
Reference_point
the previous 12 months
NCT00445029_exc_T50
Observation
earned more than 4500€ in indemnities